POC coagulation testing devices market seen reaching $3.49 billion by 2030

The point-of-care coagulation testing devices market is projected to grow from $2.55 billion in 2026 to $3.49 billion by 2030, driven by demand for faster diagnostics, home healthcare and telehealth. North America was the largest regional market in 2025, while portable monitors, home kits and wireless connectivity are shaping product trends.

Why it matters: - Point-of-care coagulation testing devices help clinicians assess blood clotting quickly outside traditional labs. - Faster testing can support earlier treatment decisions for patients with coagulation disorders or abnormal bleeding and clotting risk. - Market growth signals rising demand for rapid, decentralized diagnostics across hospitals, clinics and home care.

What happened: - The Business Research Company released an intelligence report on the global point-of-care coagulation testing devices market. - The market is projected to rise from $2.32 billion in 2025 to $2.55 billion in 2026. - The report forecasts the market will reach $3.49 billion by 2030. - North America was the largest regional market in 2025.

The details: - The market's 2025-2026 growth implies a 9.7% compound annual growth rate. - The 2026-2030 forecast implies an 8.2% compound annual growth rate. - Historic growth has been supported by rising coagulation disorders, broader anticoagulant use, decentralized healthcare and better testing technology. - Future demand is expected to come from home healthcare diagnostics, personalized medicine, telehealth-enabled diagnostics, an aging population and microfluidic testing platforms. - Key product trends include portable coagulation monitors, rapid point-of-care testing, home-based coagulation kits, wireless data connectivity and tighter focus on accuracy and reliability. - The report defines point-of-care coagulation testing devices as compact, user-friendly tools that measure blood clotting outside traditional laboratory environments. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, South America, the Middle East and Africa alongside North America. - The 2026 edition adds market attractiveness scoring, TAM analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, and updated graphics and tables. - A free sample report is available: Download a free sample. - The full report is available here: View the full report.

Between the lines: - The report ties market demand to a mix of clinical need and consumer-facing care shifts. - Rising hereditary haemophilia A cases in Australia underscore how blood-clotting disorders can increase the need for quick testing tools. - Lifestyle factors such as smoking, excessive alcohol intake and physical inactivity add another layer of demand by increasing clotting risk. - The emphasis on wireless connectivity and home-based kits suggests the market is moving toward more distributed testing workflows.

What's next: - Market expansion through 2030 will likely hinge on how quickly healthcare systems adopt portable diagnostics, telehealth-linked workflows and home testing. - Continued innovation in microfluidics and device reliability will be important as buyers weigh speed against accuracy. - Regional growth outside North America will likely depend on access to decentralized care and adoption of new testing platforms.

The bottom line: - Point-of-care coagulation testing devices are moving from niche tools to a broader diagnostic category, with growth driven by faster care delivery and more testing outside the lab.